Background Malignant central airway obstruction (CAO) occurs in approximately 20–30% of
patients with lung cancer and is associated with debilitating symptoms and poor prognosis …

Therapeutic bronchoscopy is safe and effective at improving patient-centered outcomes in
malignant CAO. Research is ongoing to better understand its optimal role in this setting …

Background While therapeutic bronchoscopy has been used to treat malignant central
(CAO) airway obstruction for> 25 years, there are no studies quantifying the impact of …

Background: A systematic assessment of comprehensive clinical outcomes after various
therapeutic procedures for malignant central airway obstruction (CAO) is lacking. Methods …

Introduction Central airway obstruction (CAO) is a life-threatening complication of lung
cancer. The prevalence of CAO in lung cancer patients is unknown. We audited CAO burden …

Background Malignant central airway obstruction (MCAO) occurs in 20–30% of patients with
primary pulmonary malignancy. Although bronchoscopic intervention is widely performed to …

Background Interventional bronchoscopy is considered an effective treatment option for
malignant central airway obstruction (MCAO). However, there are few reports of …

Background: Malignant central airway obstruction may result in an Eastern Cooperative
Oncology Group Performance Status (ECOG PS) that precludes treatment with systemic …

BACKGROUND There is significant variation between physicians in terms of how they
perform therapeutic bronchoscopy, but there are few data on whether these differences …

Abstract Background and Objective EpiGETIF is a web‐based, multicentre clinical database
created in 2019 aiming for prospective collection of data regarding therapeutic rigid …